Consistently, previous studies reported that TRX can suppress the phosphorylation of JNK in a rat model of type 2 diabetes and block TRAF2-ASK1-JNK signalling in the mouse liver [5, 54]. This evidence concerns the gene MAPK8 and type 2 diabetes mellitus.